Compounds > 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine
Page last updated: 2024-09-03

1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and moxifloxacin

1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine has been researched along with moxifloxacin in 1 studies

Compound Research Comparison

Studies
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)		Trials
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)		Recent Studies (post-2010)
(1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine)		Studies
(moxifloxacin)		Trials
(moxifloxacin)		Recent Studies (post-2010) (moxifloxacin)
14103,1575521,690

Protein Interaction Comparison

ProteinTaxonomy1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine (IC50)moxifloxacin (IC50)
DNA gyrase subunit BStaphylococcus aureus5.1033
DNA gyrase subunit AEscherichia coli K-121.4
DNA gyrase subunit BEscherichia coli K-121.4
DNA topoisomerase 4 subunit AStaphylococcus aureus0.8
DNA gyrase subunit AStaphylococcus aureus7.25
DNA gyrase subunit BMycobacterium tuberculosis H37Rv8.525
DNA gyrase subunit AMycobacterium tuberculosis H37Rv8.66

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jolivette, LJ; Nagilla, R; Ward, KW1

Other Studies

1 other study(ies) available for 1,2,3,6-tetrahydro-4-phenyl-1-((3-phenyl-3-cyclohexen-1-yl)methyl)pyridine and moxifloxacin

ArticleYear
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
    Xenobiotica; the fate of foreign compounds in biological systems, 2005, Volume: 35, Issue:2

    Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics

2005